Latest stories on RDY
Dr. Reddy's Laboratories rallies Tuesday, outperforms market
MarketWatch63 · neutralgeneral
Dr Reddy's Laboratories Ltd (RDY) Shares Surge 4.1% -- What GF Score of 83 Tells Investors
GuruFocus63 · neutralgeneral
Dr. Reddy's Laboratories: 3 Key Takeaways for Long-Term Investors
The Motley Fool58 · neutralgeneral
Dr. Reddy’s Earnings Call Highlights Growth Amid Headwinds
TipRanks58 · neutralearnings
Dr. Reddy’s outlines semaglutide relaunch in November 2026 and reiterates 6M-7M devices target
Seeking Alpha63 · neutralearnings
Dr. Reddy's Laboratories Limited (RDY) Q2 2027 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Dr. Reddy's GAAP EPS of $0.17, revenue of $1.75B
Business Insider52 · neutralearnings
Dr. Reddy’s Laboratories Files Q2 FY 2027 Unaudited Results with SEC and Indian Exchanges
TipRanks50 · neutralearnings
Dr. Reddy’s Elevates Aurigene CEO Akhil Ravi to Head API and Services
TipRanks53 · neutralgeneral
Dr. Reddy’s Interim Q2 FY 2026 Results Receive Clean Auditor Review
TipRanks56 · neutralearnings
Dr. Reddy's (RDY) Q2 2027 Earnings Call Transcript
The Motley Fool48 · neutralearnings
Dr. Reddy's Laboratories slides Friday, underperforms competitors
MarketWatch38 · neutralgeneral
Dr. Reddy's Laboratories advances Thursday, outperforms market
MarketWatch58 · neutralgeneral
Dr. Reddy's Laboratories slides Wednesday, underperforms competitors
MarketWatch38 · neutralgeneral
Dr. Reddy's Laboratories rallies Friday, outperforms competitors
MarketWatch64 · neutralgeneral
Dr. Reddy's Laboratories rallies Thursday, underperforms competitors
MarketWatch42 · neutralgeneral
Dr. Reddy’s Receives USFDA Form 483 After Pre-Approval Inspection at Visakhapatnam Plant
TipRanks38 · neutralproduct/pr
Dr. Reddy's Laboratories falls Wednesday, underperforms competitors
MarketWatch38 · neutralgeneral
Dr. Reddy’s upgraded to Outperform from Neutral at BNP Paribas
The Fly63 · neutralanalyst
Dr. Reddy's Laboratories rises Friday, outperforms competitors
MarketWatch61 · neutralgeneral
Dr. Reddy’s Receives Two-Observation USFDA Form 483 After PAI at FTO-11
TipRanks38 · neutralgeneral
Dr. Reddy's Laboratories falls Wednesday, outperforms competitors
MarketWatch58 · neutralgeneral
Dr. Reddy's Laboratories slips Thursday, underperforms competitors
MarketWatch38 · neutralgeneral
Dr. Reddy’s double-upgraded to Buy from Sell at Citi
The Fly61 · neutralanalyst
Dr. Reddy's Laboratories advances Friday, underperforms market
MarketWatch42 · neutralgeneral